课题基金 / 基金详情

NEW PATHWAYS OF CORTICOSTEROID METABOLISM

NEW PATHWAYS OF CORTICOSTEROID METABOLISM
皮质类固醇代谢的新途径
批准号:
3229872
负责人:
CARL MONDER
金额:
$31.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-10-01 至 1990-04-30

项目摘要

项目成果

CARL MONDER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our goals are to elaborate the details of and evaluate the significance of new pathways of corticosteroid metabolism. We have shown in all species studied, including man, that the ketol side chain is reversibly converted by an isomerase to an aldol configuration that can undergo further changes. Interconversion of the 20Alpha and 20Beta epimeric forms of the aldol is catalyzed by an epimerase. Either epimer is oxidized to the hydroxy acid side chain (cortic acids in man) by aldehyde dehydrogenases or reduced to glycols (cortols and cortolones in man) by aldo reductase. The properties of the enzymes that catalyze these changes, isolated from the livers of hamsters and mice, are being studied in detail in order to develop a basis for understanding how the various pathways of corticosteroid metabolism are controlled and coordinated. In parallel studies in humans, metabolic pathways corresponding to those in animals are inferred from the urinary metabolites derived from intravenously injected precursors. The metabolic and clinicophathological significance in man of the expanded pathways of corticosteroid metabolism are under study. In humans, we will use methods that we have developed in order to study how a variety of physiological conditions affect the urinary excretion of the cortoic acids. We will especiallly study infant and juvenile urine in order to establish what other steroid acid metabolites are excreted, and to isolate and identify them. The physiological fractions of the acid end-products of cortisol metabolism and the aldol intermediates will be evaluated by standard anti-inflammatory assays and by induction of specific enzymes such as tyrosines aminotransferase and glycogen synthetase which are known to respond to glucocorticoids. We will continue our studies of side chain isomerase genetics in the mouse in order to specifically map the gene and to establish its multiplicity. Our intentions are to use these studies as models for possible genetic defects of corticosteroid metabolism in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORTICOSTEROID METABOLISM IN JUVENILE HYPERTENSION
  • 批准号:
    3235796
  • 项目类别:
  • 资助金额:
    $26.06万
  • 财政年份:
    1986
  • 负责人:
    CARL MONDER
  • 依托单位:
CORTICOSTEROID METABOLISM IN JUVENILE HYPERTENSION
  • 批准号:
    3235802
  • 项目类别:
  • 资助金额:
    $22.99万
  • 财政年份:
    1986
  • 负责人:
    CARL MONDER
  • 依托单位:
CORTICOSTEROID METABOLISM IN JUVENILE HYPERTENSION
  • 批准号:
    3235798
  • 项目类别:
  • 资助金额:
    $6.81万
  • 财政年份:
    1986
  • 负责人:
    CARL MONDER
  • 依托单位:
CORTICOSTEROID METABOLISM IN JUVENILE HYPERTENSION
  • 批准号:
    3235804
  • 项目类别:
  • 资助金额:
    $27.8万
  • 财政年份:
    1986
  • 负责人:
    CARL MONDER
  • 依托单位:
海外基金